Ankita Pathak

1.1k total citations · 1 hit paper
13 papers, 827 citations indexed

About

Ankita Pathak is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ankita Pathak has authored 13 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Ankita Pathak's work include Synthesis and biological activity (4 papers), Cancer therapeutics and mechanisms (3 papers) and Synthesis and Biological Evaluation (3 papers). Ankita Pathak is often cited by papers focused on Synthesis and biological activity (4 papers), Cancer therapeutics and mechanisms (3 papers) and Synthesis and Biological Evaluation (3 papers). Ankita Pathak collaborates with scholars based in India, Saudi Arabia and Nepal. Ankita Pathak's co-authors include Mohammad Shahar Yar, Md Rafi Haider, Kumari Neha, Md Jawaid Akhtar, Kashif Haider, Ahsan Ahmed Khan, Zulphikar Ali, Rikeshwer Prasad Dewangan, Abul Kalam Najmi and Kalicharan Sharma and has published in prestigious journals such as International Journal of Biological Macromolecules, European Journal of Medicinal Chemistry and Current Medicinal Chemistry.

In The Last Decade

Ankita Pathak

12 papers receiving 806 citations

Hit Papers

Medicinal prospects of antioxidants: A review 2019 2026 2021 2023 2019 100 200 300 400 500

Peers

Ankita Pathak
Ankita Pathak
Citations per year, relative to Ankita Pathak Ankita Pathak (= 1×) peers Beatrice Polini

Countries citing papers authored by Ankita Pathak

Since Specialization
Citations

This map shows the geographic impact of Ankita Pathak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankita Pathak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankita Pathak more than expected).

Fields of papers citing papers by Ankita Pathak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankita Pathak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankita Pathak. The network helps show where Ankita Pathak may publish in the future.

Co-authorship network of co-authors of Ankita Pathak

This figure shows the co-authorship network connecting the top 25 collaborators of Ankita Pathak. A scholar is included among the top collaborators of Ankita Pathak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankita Pathak. Ankita Pathak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pathak, Ankita, et al.. (2024). ROLE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND KI67 IN EPITHELIAL OVARIAN TUMOR. Asian Journal of Pharmaceutical and Clinical Research. 153–156.
2.
Haider, Kashif, et al.. (2022). Strategies in synthetic design and structure–activity relationship studies of novel heterocyclic scaffolds as aldose reductase‐2 inhibitors. Archiv der Pharmazie. 355(12). e2200167–e2200167. 4 indexed citations
3.
Pathak, Ankita, Yuba Raj Pokharel, Vinod Devaraji, et al.. (2021). Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents. Bioorganic Chemistry. 116. 105358–105358. 14 indexed citations
5.
Haider, Kashif, Sara Rehman, Ankita Pathak, Abul Kalam Najmi, & Mohammad Shahar Yar. (2021). Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents. Archiv der Pharmazie. 354(12). 25 indexed citations
6.
Haider, Kashif, et al.. (2021). Recent advances and SAR study of 2-substituted benzothiazole scaffold based potent chemotherapeutic agents. Results in Chemistry. 4. 100258–100258. 34 indexed citations
7.
Nabi, Bushra, Saleha Rehman, Ankita Pathak, et al.. (2020). Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: Formulation perspective and In vitro and In vivo assessment. International Journal of Biological Macromolecules. 167. 605–619. 29 indexed citations
8.
Haider, Kashif, et al.. (2019). Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. European Journal of Medicinal Chemistry. 184. 111773–111773. 31 indexed citations
9.
Neha, Kumari, Md Rafi Haider, Ankita Pathak, & Mohammad Shahar Yar. (2019). Medicinal prospects of antioxidants: A review. European Journal of Medicinal Chemistry. 178. 687–704. 508 indexed citations breakdown →
10.
Akhtar, Md Jawaid, Mohammad Shahar Yar, Ahsan Ahmed Khan, et al.. (2019). Recent Progress of Benzimidazole Hybrids for Anticancer Potential. Current Medicinal Chemistry. 27(35). 5970–6014. 54 indexed citations
11.
Pathak, Ankita, et al.. (2018). Current perspectives on quinazolines with potent biological activities: A review. Synthetic Communications. 48(10). 1099–1127. 73 indexed citations
12.
Pathak, Ankita, Md Jawaid Akhtar, Md Rafi Haider, et al.. (2018). DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective. European Journal of Medicinal Chemistry. 158. 559–592. 39 indexed citations
13.
Pathak, Ankita, et al.. (2018). Emergence of promising novel DPP‐4 inhibitory heterocycles as anti‐diabetic agents: A review. Archiv der Pharmazie. 351(8). e1800127–e1800127. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026